Dietary Stilbenes As Modulators of Specific MiRNAs in Prostate Cancer

Overview

Journal Front Pharmacol

Date 2022 Sep 12

PMID 36091792

Authors

Anait S Levenson

Affiliations

Soon will be listed here.

Abstract

Accumulated experimental data have suggested that natural plant products may be effective miRNA-modulating chemopreventive and therapeutic agents. Dietary polyphenols such as flavonoids, stilbenes, and lignans, among others, have been intensively studied for their miRNA-mediated cardioprotective, antioxidant, anti-inflammatory and anticancer properties. The aim of this review is to outline known stilbene-regulated miRNAs in cancer, with a special focus on the interplay between various miRNAs and MTA1 signaling in prostate cancer. MTA1 is an epigenetic reader and an oncogenic transcription factor that is overexpressed in advanced prostate cancer and metastasis. Not surprisingly, miRNAs that are linked to MTA1 affect cancer progression and the metastatic potential of cells. Studies led to the identification of MTA1-associated pro-oncogenic miRNAs, which are regulated by stilbenes such as resveratrol and pterostilbene. Specifically, it has been shown that inhibition of the activity of the MTA1 regulated oncogenic miR-17 family of miRNAs, miR-22, and miR-34a by stilbenes leads to inhibition of prostatic hyperplasia and tumor progression in mice and reduction of proliferation, survival and invasion of prostate cancer cells . Taken together, these findings implicate the use of resveratrol and its analogs as an attractive miRNA-mediated chemopreventive and therapeutic strategy in prostate cancer and the use of circulating miRNAs as potential predictive biomarkers for clinical development.

Citing Articles

Stilbenes: a journey from folklore to pharmaceutical innovation.

Kaur G, Kaur R, Sodhi G, George N, Rath S, Walia H Arch Microbiol. 2024; 206(5):229.

PMID: 38647675 DOI: 10.1007/s00203-024-03939-z.

Stilbenes: a promising small molecule modulator for epigenetic regulation in human diseases.

Tian J, Jin L, Liu H, Hua Z Front Pharmacol. 2023; 14:1326682.

PMID: 38155902 PMC: 10754530. DOI: 10.3389/fphar.2023.1326682.

The Bone Microenvironment Soil in Prostate Cancer Metastasis: An miRNA Approach.

Prigol A, Rode M, da Luz Efe F, Saleh N, Creczynski-Pasa T Cancers (Basel). 2023; 15(16).

PMID: 37627055 PMC: 10452124. DOI: 10.3390/cancers15164027.

Inhibition of miR-20a by pterostilbene facilitates prostate cancer cells killed by NK cells via up-regulation of NKG2D ligands and TGF-β1down-regulation.

Youlin K, Simin L, Jian K, Li Z Heliyon. 2023; 9(4):e14957.

PMID: 37064475 PMC: 10102449. DOI: 10.1016/j.heliyon.2023.e14957.

Novel Insights into the Role of the Antioxidants in Prostate Pathology.

Rago V, Di Agostino S Antioxidants (Basel). 2023; 12(2).

PMID: 36829848 PMC: 9951863. DOI: 10.3390/antiox12020289.

References

Li X, Nie C, Tian B, Tan X, Han W, Wang J . miR-671-5p Blocks The Progression Of Human Esophageal Squamous Cell Carcinoma By Suppressing FGFR2. Int J Biol Sci. 2019; 15(9):1892-1904. PMC: 6743296. DOI: 10.7150/ijbs.32429. View

Kang N, Shin S, Lee H, Lee K . Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol Ther. 2011; 130(3):310-24. DOI: 10.1016/j.pharmthera.2011.02.004. View

Narayanan N, Kunimasa K, Yamori Y, Mori M, Mori H, Nakamura K . Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo. Cancer Med. 2015; 4(11):1767-80. PMC: 4674003. DOI: 10.1002/cam4.520. View

Vo N, Madlener S, Bago-Horvath Z, Herbacek I, Stark N, Gridling M . Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells. Carcinogenesis. 2009; 31(12):2074-81. DOI: 10.1093/carcin/bgp199. View

Qin W, Shi Y, Zhao B, Yao C, Jin L, Ma J . miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One. 2010; 5(2):e9429. PMC: 2828487. DOI: 10.1371/journal.pone.0009429. View

Qin W, Zhang K, Clarke K, Weiland T, Sauter E . Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue. Nutr Cancer. 2014; 66(2):270-7. DOI: 10.1080/01635581.2014.868910. View

Liu Y, Lu L, Wen D, Liu D, Dong L, Gao D . MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming. J Hematol Oncol. 2020; 13(1):12. PMC: 7006096. DOI: 10.1186/s13045-019-0841-3. View

Shen T, Wang X, Lou H . Natural stilbenes: an overview. Nat Prod Rep. 2009; 26(7):916-35. DOI: 10.1039/b905960a. View

Vanden Berghe W . Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. Pharmacol Res. 2012; 65(6):565-76. DOI: 10.1016/j.phrs.2012.03.007. View

10.

Ambs S, Prueitt R, Yi M, Hudson R, Howe T, Petrocca F . Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008; 68(15):6162-70. PMC: 2597340. DOI: 10.1158/0008-5472.CAN-08-0144. View

11.

Valeri N, Vannini I, Fanini F, Calore F, Adair B, Fabbri M . Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation. Mamm Genome. 2009; 20(9-10):573-80. DOI: 10.1007/s00335-009-9206-5. View

12.

Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J . Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016; 7(14):18469-84. PMC: 4951302. DOI: 10.18632/oncotarget.7841. View

13.

Ma C, Zhang Y, Tang L, Yang X, Cui W, Han C . MicroRNA-1469, a p53-responsive microRNA promotes Genistein induced apoptosis by targeting Mcl1 in human laryngeal cancer cells. Biomed Pharmacother. 2018; 106:665-671. DOI: 10.1016/j.biopha.2018.07.005. View

14.

Li X, Pan J, Song B, Xiong E, Chen Z, Zhou Z . Suppression of CX43 expression by miR-20a in the progression of human prostate cancer. Cancer Biol Ther. 2012; 13(10):890-8. DOI: 10.4161/cbt.20841. View

15.

Selth L, Townley S, Gillis J, Ochnik A, Murti K, Macfarlane R . Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int J Cancer. 2011; 131(3):652-61. DOI: 10.1002/ijc.26405. View

16.

Perl A, Wilgenbus P, Dahl U, Semb H, Christofori G . A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998; 392(6672):190-3. DOI: 10.1038/32433. View

17.

Su L, David M . Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol. J Biol Chem. 2000; 275(17):12661-6. DOI: 10.1074/jbc.275.17.12661. View

18.

Song S, Poliseno L, Song M, Ala U, Webster K, Ng C . MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell. 2013; 154(2):311-324. PMC: 3767157. DOI: 10.1016/j.cell.2013.06.026. View

19.

Kapetanovic I, Muzzio M, Huang Z, Thompson T, McCormick D . Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol. 2010; 68(3):593-601. PMC: 3090701. DOI: 10.1007/s00280-010-1525-4. View

20.

Ventura A, Jacks T . MicroRNAs and cancer: short RNAs go a long way. Cell. 2009; 136(4):586-91. PMC: 3910108. DOI: 10.1016/j.cell.2009.02.005. View